Treatments (n) | With ptosis (n) | Ptosis % (95% CI) | Peak improvement % (95% CI) | Duration of improvement months (95% CI) | Upper eyelid dose mean (95% CI) | |
---|---|---|---|---|---|---|
Group A | 508 | 138 | 27.17 (22.18–32.79) | 77.76 (75.74–79.78) | 3.39 (3.19–3.54) | 19.35 (18.89–19.77) |
Group B | 217 | 21 | 9.67 (6.13–15.35) | 74.93 (71.44–78.42) | 3.33 (3.09–3.57) | 19.77 (19.18–20.35) |
p Value | <0.001 | 0.770 | 0.063 | 0.247 |
Group A = injection was made into the junction of the orbital and preseptal orbicularis oculi (site A).
Group B = injection was made into the lateral part of orbital orbicularis oculi (site B).